Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caudal bupivacaine combinations for postoperative analgesia in children undergoing lower abdominal surgery
IRCT20240610062072N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine + magnesium sulfate, Bupivacaine + dexmedetomidine and Bupivacaine + midazolam (3 arms). Primary endpoints: Visual Analog Scale score, CHEOPS score and 4 more. Started Jun 2024; status: completed.
02
Drugs
bupivacainemagnesium sulfatedexmedetomidinemidazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20240610062072N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240610062072N1.